Abstract
Alzheimer’s disease (AD), the most common form of dementia, is a growing problem worldwide, with 10 million incident cases registered every year. The complex etiology of AD has not been clarified yet and represents an active research topic. In this work, we studied the inhibitory properties of Hp-1935, a natural peptide extracted from the skin secretions of an Argentinian frog (Boana pulchella). It was initially isolated as an antimicrobial peptide by our group, but we later discovered its anti-AChE action. Since not many peptides with this activity have been reported, we focused on defining the basis of its inhibitory mechanism against acetylcholinesterase (AChE) and on finding the primary portion for the inhibitory activity in its sequence, through the combination of an experimental strategy of design and synthesis with molecular dynamics simulations. We also tested its cytotoxicity. We found that Hp-1935 is an interesting sequence for the development of new AChE inhibitors. This peptide is a peripheral anionic site inhibitor with an inhibitory activity that collocates it between the most potent natural amino acids peptides against AChE reported. We also demonstrate that its inhibitory activity is concentrated on the central part of the sequence.
This is a preview of subscription content, access via your institution.
References
Alvarez A, Alarcón R, Opazo C et al (1998) Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J Neurosci 18(9):3213–3223. (PMID: 9547230)
Anand P, Singh B (2013) A review on cholinesterase inhibitors for Alzheimer’s disease. Arch Pharm Res 36(4):375–399. https://doi.org/10.1007/s12272-013-0036-3
Atta-ur-Rahman A, Choundary MI (2015) Drug design and discovery in Alzheimer's disease. Bentham Science Publishers, Sharjah
Atta-ur-Rahman A, Reitz AB, Choudhary MI (2010) Frontiers in medicinal chemistry, vol 5. Bentham Science Publishers, Sharjah
Bartolini M, Bertucci C, Cavrini V, Andrisano V (2003) beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol 65(3):407–416. https://doi.org/10.1016/s0006-2952(02)01514-9
Bartus RT, Dean RL III, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558):408–414. https://doi.org/10.1126/science.7046051
Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684. https://doi.org/10.1063/1.448118
Borges-Machado F, Ribeiro O, Sampaio A (2018) Feasibility and impact of a multicomponent exercise intervention in patients with Alzheimer’s disease: a pilot study. Am J Alzheimers Dis Other Dement 34(2):95–103. https://doi.org/10.1177/1533317518813555
Branduardi D, Gervasio FL, Cavalli A, Recanatini M, Parrinello M (2005) The role of the peripheral anionic site and cation-pi interactions in the ligand penetration of the human AChE gorge. J Am Chem Soc 127(25):9147–9155. https://doi.org/10.1021/ja0512780
Case DA, Ben-Shalom IY, Brozell SR et al (2018) AMBER 2018. University of California, San Francisco
Copeland RA (2005) Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists, 2nd edn. Wiley, Hoboken
Cummings J, Leeb G, Ritter A et al (2019) Alzheimer's disease drug development pipeline: 2019. Alzheimer’s Dement (NY). 5:272–293. https://doi.org/10.1016/j.trci.2019.05.008
Daneshmand F, Zare-Zardini H, Ebrahimi L (2013) Investigation of the antimicrobial activities of Snakin-Z, a new cationic peptide derived from Zizyphus jujuba fruits. Nat Prod Res 27(24):2292–2296. https://doi.org/10.1080/14786419.2013.827192
de la Torre GB, Albericio F (2018) The pharmaceutical industry in 2018. An analysis of FDA drug approvals from the perspective of molecules n analysis of FDA drug approvals from the perspective of molecules. Molecules 24(4):E809. https://doi.org/10.3390/molecules24040809
de Souza ON, Ornstein RL (1997) Effect of warmup protocol and sampling time on convergence of molecular dynamics simulations of a DNA dodecamer using AMBER 41 and particle-mesh Ewald method. J Biomol Struct Dyn 14(5):607–611. https://doi.org/10.1080/07391102.1997.10508160
Dominguez C, Boelens R, Bonvin AM (2003) HADDOCK: a protein-protein docking approach based on biochemical and/or biophysical information. J Am Chem Soc 125(7):1731–1737. https://doi.org/10.1021/ja026939x
Dos Santos TC, Gomes TM, Pinto BAS, Camara AL, Paes AMA (2018) Naturally occurring acetylcholinesterase inhibitors and their potential use for Alzheimer's disease therapy. Front Pharmacol 9:1192. https://doi.org/10.3389/fphar.2018.01192
Dvir H, Silman I, Harel M, Rosenberry TL, Sussman JL (2010) Acetylcholinesterase: from 3D structure to function. Chem Biol Interact 187(1–3):10–22. https://doi.org/10.1016/j.cbi.2010.01.042
Ellman GL, Courtney KD, Andres VJR, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95. https://doi.org/10.1016/0006-2952(61)90145-9
Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM (2016) Alzheimer's disease: targeting the cholinergic system. Curr Neuropharmacol 14(1):101–115. https://doi.org/10.2174/1570159X13666150716165726
Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20(1):122–128. https://doi.org/10.1016/j.drudis.2014.10.003
Götz AW, Williamson MJ, Xu D, Poole D, Le Grand S, Walker RC (2012) Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. J Chem Theory Comput. 8(5):1542–1555. https://doi.org/10.1021/ct200909j
Grossberg GT, Tong G, Burke AD, Tariot PN (2019) Present algorithms and future treatments for Alzheimer’s disease. J Alzheimer’s Dis 67(4):1157–1171. https://doi.org/10.3233/JAD-180903
Hardy JA, Higgings GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185. https://doi.org/10.1126/science.1566067
Harel M, Schalk I, Ehret-Sabatier L et al (1993) Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci 90(19):9031–9035. https://doi.org/10.1073/pnas.90.19.9031
Knez D, Coquelle N, Pišlar A et al (2018) Multi-target-directed ligands for treating Alzheimer's disease: butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities. Eur J Med Chem 5(156):598–617. https://doi.org/10.1016/j.ejmech.2018.07.033
Lau JL, Dunn MK (2018) Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem 26(10):2700–2707. https://doi.org/10.1016/j.bmc.2017.06.052
Lilienfeld S (2002) Galantamine—a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. CNS Drug Rev 8(2):159–176. (PMID: 12177686)
Liu Y, Yan B, Winkler DA, Fu J, Zhang A (2017) Competitive inhibition mechanism of acetylcholinesterase without catalytic active site interaction: study on functionalized C60 nanoparticles via in vitro and in silico assays. ACS Appl Mater Interfaces 9(22):18626–18638. https://doi.org/10.1021/acsami.7b05459
Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11(8):3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
Nabil ZI, Hussein AA, Zalat SM, Rakha MKH (1998) Mechanism of action of honey bee (Apis mellifera L.) venom on different types of muscles. Hum Exp Toxicol 17(3):185–190. https://doi.org/10.1177/096032719801700311
Pastor RW, Brooks BR, Szabo A (1988) An analysis of the accuracy of Langevin and molecular dynamics algorithms. Mol Phys 65:1409–1419. https://doi.org/10.1080/00268978800101881
Pietsch M, Christian L, Inhester T, Petzold S, Gütschow M (2009) Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile. FEBS J 276(8):2292–2307. https://doi.org/10.1111/j.1742-4658.2009.06957.x
Pimplikar SW (2009) Reassessing the amyloid cascade hypothesis of Alzheimer’s disease. Int J Biochem Cell Biol 41(6):1261–1268. https://doi.org/10.1016/j.biocel.2008.12.015
Pohanka M (2011) Cholinesterases, a target of pharmacology and toxicology. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155(3):219–229. https://doi.org/10.5507/bp.2011.036
Pomorska G, Ockeneb JK (2017) A general neurologist's perspective on the urgent need to apply resilience thinking to the prevention and treatment of Alzheimer's disease. Alzheimers Dement (N Y). 3(4):498–506. https://doi.org/10.1016/j.trci.2017.08.001
Prasasty V, Radifar M, Istyastono E (2018) Natural peptides in drug discovery targeting acetylcholinesterase. Molecules 23(9):E2344. https://doi.org/10.3390/molecules23092344
Rastegari A, Nadri H, Mahdavi M et al (2018) Design, synthesis and anti-Alzheimer's activity of novel 1,2,3-triazole-chromenone carboxamide derivatives. Bioorg Chem 83:391–401. https://doi.org/10.1016/j.bioorg.2018.10.065
Rastelli G, Del Rio A, Degliesposti G, Sgobba M (2010) Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J Comput Chem 31(4):797–810. https://doi.org/10.1002/jcc.21372
Raves ML, Harel M, Pang YP, Silman I, Kozikowski AP, Sussman JL (1997) Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A. Nat Struct Biol 4(1):57–63. (PMID: 8989325)
Reyes AE, Chacón MA, Dinamarca MC, Cerpa W, Morgan C, Inestrosa NC (2004) Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am J Pathol 164(6):2163–2174. https://doi.org/10.1016/s0002-9440(10)63774-1
Rodríguez-Ithurralde D, Silveira R, Barbeito L, Dajas F (1983) Fasciculin, a powerful anticholinesterase polypeptide from Dendroaspis angusticeps venom. Neurochem Int 5(3):267–274. (PMID: 20487949)
Salomon-Ferrer R, Götz AW, Poole D, Le Grand S, Walker RC (2013) Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. explicit solvent particle Mesh Ewald. J Chem Theory Comput 9(9):3878–3888. https://doi.org/10.1021/ct400314y
Sánchez-Chávez G, Salceda R (2008) Enzimas polifuncionales: el caso de la acetilcolinesterasa. Rev Educ Bioquim 27(2):44–51
Schneider LS (2000) A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease. Dialogues Clin Neurosci 2(2):111–128
Shen Y, Maupetit J, Derreumaux P, Tufféry P (2014) Improved PEP-FOLD approach for peptide and miniprotein structure prediction. J Chem Theor Comput 10:4745–4758. https://doi.org/10.1021/ct500592m
Siano A, Húmpola MV, de Oliveira E, Albericio F, Simonetta AC, Lajmanovich R, Tonarelli GG (2014) Antimicrobial peptides from skin secretions of Hypsiboas pulchellus (Anura: Hylidae). J Nat Prod 77(4):831–841. https://doi.org/10.1021/np4009317
Siano A, Garibotto FF, Andujar SA, Baldoni HA, Tonarelli GG, Enriz RD (2017) Molecular design and synthesis of novel peptides from amphibians skin acting as inhibitors of cholinesterase enzymes. J Pept Sci 23(3):236–244. https://doi.org/10.1002/psc.2974
Silman I, Sussman JL (2005) Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. Curr Opin Pharmacol 5(3):293–302. https://doi.org/10.1016/j.coph.2005.01.014
Spinelli R, Sanchis I, Aimaretti FM, Attademo AM, Portela M, Humpola MV, Tonarelli GG, Siano AS (2019) Natural Multi-target inhibitors of cholinesterases and monoamine oxidase enzymes with antioxidant potential from skin extracts of Hypsiboas cordobae and Pseudis minuta (Anura: Hylidae). Chem Biodivers 16(1):e1800472. https://doi.org/10.1002/cbdv.201800472
Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I (1991) Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253(5022):872–879. https://doi.org/10.1126/science.1678899
Thévenet P, Shen Y, Maupetit J, Guyon F, Derreumaux P, Tufféry P (2012) PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res 40:W288–293. https://doi.org/10.1093/nar/gks419
Tsui V, Case DA (2000) Theory and applications of the generalized Born solvation model in macromolecular simulations. Biopolymers 56(4):275–291. https://doi.org/10.1002/1097-0282(2000)56:4%3c275:AID-BIP10024%3e3.0.CO;2-E
van Zundert GCP, Rodrigues JPGLM, Trellet M et al (2015) The HADDOCK22 Web server: user-friendly integrative modeling of biomolecular complexes. J Mol Biol 428(4):720–725. https://doi.org/10.1016/j.jmb.2015.09.014
Wang H, Zhang H (2019) Reconsideration of anticholinesterase therapeutic strategies against Alzheimer's disease. ACS Chem Neurosci 10(2):852–862. https://doi.org/10.1021/acschemneuro.8b00391
Wang G, Li X, Wang Z (2016a) APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res 44(D1):D1087–D1093. https://doi.org/10.1093/nar/gkv1278
Wang L, Chen L, Yu M, Xu LH, Cheng B, Lin YS, Gu Q, He XH, Xu J (2016b) Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays. Sci Rep. 6(6):18987. https://doi.org/10.1038/srep18987
WHO (2019) Dementia. https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed 26 Jun 2019
Xie YC, Ning N, Zhu L, Li DN, Feng X, Yang XP (2016) Primary investigation for the mechanism of Biatractylolide from Atractylodis Macrocephalae Rhizoma as an Acetylcholinesterase Inhibitor. Evid Based Complement Alternat Med 2016:7481323. https://doi.org/10.1155/2016/7481323
Yu Z, Wu S, Zhao W, Ding L, Fan Y, Shiuan D, Liu J, Chen F (2018) Anti-Alzheimers activity and molecular mechanism of albumin-derived peptides against AChE and BChE. Food Funct 9(2):1173–1178. https://doi.org/10.1039/c7fo01462g
Zoete V, Irving MB, Michielin O (2010) MM-GBSA binding free energy decomposition and T cell receptor engineering. J Mol Recognit 23(2):142–152. https://doi.org/10.1002/jmr.1005
Zueva IV, Semenov VE, Mukhamedyarov MA et al (2015) 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease. Int J Risk Saf Med 27(Suppl1):S69–S71. https://doi.org/10.3233/JRS-150694
Acknowledgements
The work was supported by grants from the Universidad Nacional del Litoral (CAI + D Research Programs (PJ50020150100044LI) and Agencia Nacional de Promoción Científica y Tecnológica (PICT-2017-0035)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest among all authors of this manuscript, and no patients or animals were involved in this research.
Additional information
Handling Editor: K. Aoyama.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sanchis, I., Spinelli, R., Aschemacher, N. et al. Acetylcholinesterase inhibitory activity of a naturally occurring peptide isolated from Boana pulchella (Anura: Hylidae) and its analogs. Amino Acids 52, 387–396 (2020). https://doi.org/10.1007/s00726-019-02815-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-019-02815-1
Keywords
- Peptides
- Synthesis
- Cholinesterase inhibitors
- Alzheimer’s disease